Clinical Research Directory
Browse clinical research sites, groups, and studies.
A Study of BBT002 in Healthy Volunteers (HVs) and in Patients With Chronic Obstructive Pulmonary Disease (COPD)
Sponsor: Bambusa Therapeutics
Summary
This study is a randomized, double-Blind, placebo-controlled, Single- and Multiple-ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, Pharmacodynamics and Clinical Activity of BBT002 in Healthy Volunteers and Participants with Chronic Obstructive Pulmonary Disease (COPD).
Official title: A Randomized, Double-Blind, Placebo-controlled, Single- and Multiple-ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Immunogenicity, Pharmacodynamics and Clinical Activity of BBT002 in Healthy Volunteers and Participants With Chronic Obstructive Pulmonary Disease (COPD)
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
68
Start Date
2025-09-05
Completion Date
2027-05-30
Last Updated
2026-01-07
Healthy Volunteers
Yes
Interventions
BBT002
BBT002 will be administered
Placebo
Placebo will be administered
Locations (11)
The Second Hospital of Anhui Medical Univesity
Hefei, Anhui, China
The third affiliated hosptial of Guangzhou Medical University
Guangzhou, Guangdong, China
The First Affiliated Hospital of Guangdong Medical University
Guangzhou, Guangdong, China
Jiangmen Central Hospital
Jiangmen, Guangdong, China
Qingyuan People's Hospital
Qingyuan, Guangdong, China
The First People's Hospital of Xinxiang City
Xinxiang, Henan, China
Yichang Central People's Hospital
Yichang, Hubei, China
The Affiliated Hospital of Xuzhou Medical University
Xuzhou, Jiangsu, China
Jiangxi Provincial People's Hospital
Nanchang, Jiangxi, China
Chengdu fifth People's Hospital
Chengdu, Sichuang, China
Zhejiang Provincial People's Hospital
Hangzhou, Zhejiang, China